Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 23, 2021

View Archived Issues

Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy

AMP-CpG-adjuvanted vaccine confers potent immunity against SARS-CoV-2 infection

CLEC4G and CD209 block SARS-CoV-2 entry into host cell

Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors

New IL-17 modulators identified at UCB

ShanghaiTech University describes IKZF1/IKZF3 degradation inducers

BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors

MIPS-521 exerts analgesic efficacy through stabilization of GPCR-G protein complex dynamics

Compound from a new class of antimalarials shows activity in vitro and in vivo

Immunic signs license agreement for DHODH inhibitors and nucleoside analogues for viral infections

Preclinical evaluation of novel mAChR subtype-selective M1 PAMs

NanoViricides reports preclinical data on NV-CoV-2-R

Characterization of potent and selective inhibitors of BET BD2

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

BiVictriX completes two antibody discovery campaigns in support of BVX-001

Hexagon Bio raises funds to advance preclinical pipeline in oncology and infectious diseases

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

AbCellera and Everest Medicines collaborate to discover therapeutic antibodies

MDL-001 shown to protect mice against COVID-19-mediated weight loss

Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis

VaxEquity collaborates with AstraZeneca to progress saRNA platform technology

Lymph dysfunction identified as potential metabolic target

Mydecine reports preclinical data supporting MYCO-003 for anxiety and PTSD

Supera-CBD has superior potency over plant-derived CBD by factor of 8,000 times

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...